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EXPLAIN YOURSELF: FEDERAL
CIRCUIT REVIEW OF PTAB DECISIONS
UNDER THE APA
M. ANDREW HOLTMAN, CLARA N. JIMÉNEZ, AND SAMHITHA
MURALIDHAR MEDATIA*
INTRODUCTION
The U.S. Court of Appeals for the Federal Circuit (“Federal Circuit”)
retains exclusive jurisdiction over appeals of final written decisions from the
United States Patent and Trademark Office (“USPTO”) Patent Trial and
Appeal Board (“PTAB”).1 And because the PTAB acts as the adjudicatory
arm of the USPTO, a federal agency, Federal Circuit review of PTAB
decisions is subject to the Administrative Procedure Act (“APA”).2 Section
706 of the APA provides that a reviewing court shall, among other things,
“hold unlawful and set aside agency action, findings, and conclusions found

* M. Andrew Holtman, Ph.D. is a partner in the Washington, D.C. office of Finnegan, Henderson,
Farabow, Garrett & Dunner LLP. Andrew is one of the country’s most active patent attorneys before the
Patent Trial and Appeal Board (“PTAB”) of the USPTO, and happily practices in numerous technology
areas. Clara N. Jiménez is an associate in the Washington, D.C. office of Finnegan, Henderson, Farabow,
Garrett & Dunner LLP. She practices all aspects of patent law, with an emphasis in the chemical industry.
Samhitha Muralidhar Medatia is an associate in the Atlanta, Georgia office of Finnegan, Henderson,
Farabow, Garrett & Dunner LLP. She brings her experience as an appellate law clerk to the Honorable
Jimmy V. Reyna at the Federal Circuit and her training as a chemical engineer to her patent law practice
focusing on all aspects of patent litigation.
1. The relevant statutory provisions: “The United States Court of Appeals for the Federal Circuit
shall have exclusive jurisdiction of an appeal from a decision of the Patent Trial and Appeal Board of the
United States Patent and Trademark Office with respect to. . .inter partes review under title 35[.]” 28
U.S.C. § 1295(a)(4)(A) (2012); “A party dissatisfied with the final written decision of the Patent Trial
and Appeal Board under section 318(a) may appeal the decision pursuant to sections 141 through 144.
Any party to the inter partes review shall have the right to be a party to the appeal.” 35 U.S.C. § 319
(2012); “A party to an inter partes review or a post-grant review who is dissatisfied with the final written
decision of the Patent Trial and Appeal Board under section 318(a) or 328(a) (as the case may be) may
appeal the Board’s decision only to the United States Court of Appeals for the Federal Circuit.” 35 U.S.C.
§ 141(c) (2012).
2. See, e.g., Rovalma, S.A. v. Bohler-Edelstahl GmbH & Co. KG, 856 F.3d 1019, 1024 (Fed. Cir.
2017) (“We review the Board’s decisions under the Administrative Procedure Act (APA).”).
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to be. . .arbitrary, capricious, an abuse of discretion, or otherwise not in
accordance with law,” “without observance of procedure required by law,”
or “unsupported by substantial evidence.” 3 Translating this standard into
practice, the Federal Circuit has required that the PTAB provide “a
sufficiently detailed explanation of its determinations both to enable
meaningful judicial review and to prevent judicial intrusion on agency
authority.”4 When the Federal Circuit finds that the PTAB fails to meet this
standard, the Federal Circuit remands (or, more rarely, reverses) decisions to
the PTAB for further clarity.
This article examines instances when the Federal Circuit remanded the
case to the PTAB for failure to comply with the substantive requirements of
the APA and analyzes how the PTAB addressed the issues post-remand. The
article proceeds in four Parts. Part I describes some of the unique challenges
present in PTAB practice that may give rise to APA issues in agency trials.
Part II discusses the standards for substantive APA review. Part III explores
examples of how the Federal Circuit reviews and accounts for perceived
APA violations, and discusses how the PTAB handles these remanded
decisions. Part IV concludes with suggestions and practice pointers in view
of either defending or raising such APA challenges at the Federal Circuit.
I. UNIQUE ASPECTS OF PTAB PRACTICE
Certain rules and regulations covering post-grant proceedings at the
PTAB provide tight control over the proceeding without much room for
deviation. For example, except for good cause shown, the PTAB must
conclude its review in an inter partes review (“IPR”) within one year, per
congressional mandate.5 The USPTO’s regulations provide for “just, speedy,
and inexpensive resolution of every proceeding.” 6 To that end, there are
strict limits on the length of pleadings in all phases of the IPR, beginning
with the pre-institution petitions and preliminary patent owner responses,

3. 5 U.S.C. § 706 (2012).
4. Rovalma, 856 F.3d at 1024 (citing SEC v. Chenery Corp., 318 U.S. 80, 88, 94 (1943)).
5. The statute provides: “[The Director shall prescribe regulations]. . .requiring that the final
determination in an inter partes review be issued not later than 1 year after the date on which the Director
notices the institution of a review under this chapter, except that the Director may, for good cause shown,
extend the 1-year period by not more than 6 months, and may adjust the time periods in this paragraph in
the case of joinder under section 315(c).” 35 U.S.C. § 316(a)(11) (2012).
6. 37 C.F.R. § 42.1(b) (2017).
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and continuing with the trial-phase replies and patent owner responses.7 That
is to say, each argument a party makes has limited space in its papers before
the PTAB.
Discovery at the PTAB is also limited.8 Initial disclosures, while not
required, may be exchanged, either by party agreement or motion. 9
Additional routine discovery includes submission of any exhibit cited in a
paper or testimony, cross-examination of affidavit testimony, and “unless
previously served, a party must serve relevant information that is
inconsistent with a position advanced by the party during the proceeding
concurrent with the filing of the documents or things that contains the
inconsistency.”10 The parties may also agree to additional discovery.11 If the
parties cannot agree, one party may move for additional discovery but must
show that such “additional discovery is in the interests of justice, except in
post-grant reviews where additional discovery is limited to evidence directly
related to factual assertions advanced by either party in the proceeding.”12
The Federal Circuit has recognized the strict constraints on post-grant
practice that the PTAB’s regulations place on the parties, concluding that “in
some cases, a challenge can fail even if different evidence and arguments
might have led to success.”13
Added together, this creates a situation at the PTAB wherein the parties
are under tight word limits to make their arguments, the parties have limited
discovery opportunities, and except for good cause shown, the
Administrative Patent Judges (“APJ”) must conclude with a final written
decision within one year of institution.
II. APA STANDARDS AT THE FEDERAL CIRCUIT
The APA provides that any aggrieved party adversely affected by an
agency’s action is entitled to judicial review of that action, subject to other
7. 37 C.F.R. § 42.24 (2017) (mandating, e.g., a 14,000-word limit for petitions requesting IPR; the
same limit for patent owner preliminary responses and post-institution responses; and a 5,600-word limit
for replies to patent owner responses).
8. 37 C.F.R. § 42.51(b) (2017) (“A party is not entitled to discovery except as provided in
paragraph (a) of this section, or as otherwise authorized in this subpart.”).
9. 37 C.F.R. § 42.51(a)(1) (2017) (“Parties may agree to mandatory discovery requiring the initial
disclosures set forth in the Office Patent Trial Practice Guide.”); 37 C.F.R. § 42.51(a)(2) (2017) (Where
the parties fail to agree to the mandatory discovery set forth in paragraph (a)(1), a party may seek such
discovery by motion.”).
10. 37 C.F.R. § 42.51(b)(1) (2017).
11. 37 C.F.R. § 42.51(b)(2) (2017).
12. 37 C.F.R. § 42.51(b)(2)(i) (2017).
13. Ariosa Diagnostics v. Verinata Health, Inc., 805 F.3d 1359, 1367 (Fed. Cir. 2015).
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limits of such review.14 Such limits include, for example, traditional Article
III standing requirements.15 The Federal Circuit has confirmed that the APA
provides an independent basis for the reviewability of PTAB actions.16 And
the Federal Circuit remands, or sometimes reverses, decisions that it finds
fail to meet the APA’s requirements.17
The APA standard of review accounts for both substantive explanation
and procedural fairness. On substantive issues, the Federal Circuit will “hold
unlawful and set aside agency action, findings, and conclusions found to be.
. .arbitrary, capricious, an abuse of discretion, or otherwise not in accordance
with law,” or “unsupported by substantial evidence.” 18 Procedurally,
decisions may be held unlawful if the PTAB conducted the proceeding
“without observance of procedure required by law.”19 This paper deals only
with the Federal Circuit’s treatment of substantive violations of the APA.
Focusing in on substance, the Federal Circuit does not require the PTAB
to provide “ideal clarity” for its decisions. Instead, the Federal Circuit will
“uphold a decision of less than ideal clarity if the agency’s path may
reasonably be discerned.”20 The Federal Circuit will not, however, “supply a

14. The statute provides: “A person suffering legal wrong because of agency action, or adversely
affected or aggrieved by agency action within the meaning of a relevant statute, is entitled to judicial
review thereof. Nothing herein (1) affects other limitations on judicial review or the power or duty of the
court to dismiss any action or deny relief on any other appropriate legal or equitable ground; or (2) confers
authority to grant relief if any other statute that grants consent to suit expressly or impliedly forbids the
relief which is sought.” 5 U.S.C. § 702 (2012).
15. JTekt Corp. v. GKN Auto. Ltd., 898 F.3d 1217, 1221 (Fed. Cir. 2018) (finding IPR petitioner
lacked Article III standing where petitioner did not have “. . .concrete plans for future activity that
create[d] a substantial risk of future infringement. . .”).
16. The court in Arthrex states as follows: “The first issue is whether the adverse final judgment is
appealable. . . .The Supreme Court has recognized ‘the strong presumption that Congress intends judicial
review of administrative action.’ Here, the language of 28 U.S.C. § 1295 appears to provide for appeal. .
. .We need not decide whether the right to appeal comes directly from § 1295 or in conjunction with § 704
of the [Administrative Procedure Act]. Both statutes play a role in defining the reviewability of [PTAB]
decisions.” Arthrex, Inc. v. Smith & Nephew, Inc., 880 F.3d 1345, 1348, 1348 n.1 (Fed. Cir. 2018)
(citations omitted).
17. E.g., Ariosa, 805 F.3d at 1359 (remanding); Arendi S.A.R.L. v. Apple Inc., 832 F.3d 1355,
1366 (Fed. Cir. 2016) (reversing). Although not based exclusively on APA-related issues, a study
indicated that, from September 2012 through December 2018, the Federal Circuit has remanded over 14
percent of decisions from the PTAB. LegalMetric Custom Report, Remands of PTAB Appeals Sept. 2012
to Dec. 2018 at 2 (on file with author).
18. Rovalma, S.A. v. Bohler-Edelstahl GmbH & Co., 856 F.3d 1019, 1024 (Fed. Cir. 2017) (quoting
5 U.S.C. § 706).
19. Id.
20. Id.
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reasoned basis for the agency’s action that the agency itself has not given.”21
The PTAB must articulate logical and rational reasons for its decisions.22
The basis for not affirming decisions that the Federal Circuit finds
inadequately explained is grounded in a separation-of-powers concern: the
court wants to avoid “judicial intrusion on agency authority.”23 The Federal
Circuit has explained that this requirement is rooted in two Supreme Court
rationales that predate the APA. The first was a concern that the judiciary
could not exercise its duty of review unless it were advised of the
considerations underlying the agency action.24 The second was a concern
that the judiciary, without a clear explanation of agency action, would
intrude on agency authority to make factual, policy, and discretionary
determinations committed to the agency.25
III. FEDERAL CIRCUIT DECISIONS REVIEWING PTAB DETERMINATIONS
Against this backdrop, the Federal Circuit will critically analyze PTAB
decisions and remand, or sometimes reverse, those it finds to be inadequately
explained.26 In Arendi S.A.R.L. v. Apple Inc., the Federal Circuit reversed,
rather than remanded, an IPR determination. 27 The Federal Circuit
determined that the PTAB improperly found claims obvious by relying on
“common sense” without further analysis.28 Instead of remanding to allow
the PTAB an opportunity to elaborate on its reasoning, the Federal Circuit
found that this was “not a case where a more reasoned explanation than that
provided by the [PTAB] can be gleaned from the record.”29
It is more common for the Federal Circuit to remand decisions that it
finds insufficiently explained.30 In In re Van Os, for example, which dealt
21. Id. (citing Bowman Transp. Inc. v. Ark.-Best Freight Sys., Inc., 419 U.S. 281, 285–86 (1974);
SEC v. Chenery Corp., 332 U.S. 194, 196–97 (1947)).
22. Pers. Web Techs., LLC. v. Apple Inc., 848 F.3d 987, 992 (Fed. Cir. 2017) (citing Synopsys, Inc.
v. Mentor Graphics Corp., 814 F.3d 1309, 1322 (Fed. Cir. 2016)).
23. Id. at 992; see also Rovalma, 856 F.3d at 1024 (“Thus the Board must, as to issues made material
by the governing law, set forth a sufficiently detailed explanation of its determinations both to enable
meaningful judicial review and to prevent judicial intrusion on agency authority.”) (citations omitted).
24. Pers. Web, 848 F.3d at 992 (citing SEC v. Chenery Corp., 318 U.S. 80, 94 (1943)).
25. Id.
26. The Federal Circuit may also reverse in cases where it finds that the PTAB’s conclusions lack
substantial evidence. E.g., DSS Tech. Mgmt., Inc. v. Apple Inc., 885 F.3d 1367 (Fed. Cir. 2018).
27. 832 F.3d 1355, 1366 (Fed. Cir. 2016).
28. Id.
29. Id.
30. See, e.g., BASF Corp. v. Enthone, Inc., 749 Fed. Appx. 978 (Fed. Cir. 2018) (unpublished);
Emerson Elec. Co. v. SIPCO, LLC, 745 Fed. Appx. 369 (Fed. Cir. 2018) (unpublished); Arista Networks,
Inc. v. Cisco Sys., Inc., 726 Fed. Appx. 787 (Fed. Cir. 2018) (unpublished); L.A. Biomedical Res. Inst.
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with an appeal from an examiner’s obviousness rejection during patent
prosecution, the Federal Circuit remanded the PTAB’s decision finding that
pending claims would have been obvious.31 The Federal Circuit reasoned
that the PTAB’s rationale for a motivation to combine was lacking: “Absent
some articulated rationale, a finding that a combination of prior art would
have been ‘common sense’ or ‘intuitive’ is no different than merely stating
the combination ‘would have been obvious.’”32 Reasoning that the decision
was “potentially lawful but insufficiently or inappropriately explained,” the
Federal Circuit, vacated and remanded for further proceedings.33 In dissent,
Judge Newman opined that she would have reversed the PTAB’s decision
and ordered the challenged claims be allowed.34 She reasoned that the PTAB
erred not on account of “a lack of specificity or absence of citation to the
record or to legal authority,” but rather because it failed to meet its
“statutorily required burden of demonstrating unpatentability.”35
After a remand based on APA violations, the PTAB often adopts
procedures, like granting further briefing, to address those deficiencies. The
additional procedures sometimes, though not always, lead to a different
result than the original.
Ariosa Diagnostics v. Verinata Health, Inc. provides an example of the
PTAB’s briefing procedures on remand when the PTAB’s legal justification
for discounting potentially critical evidence was unclear. In the case, Ariosa
petitioned for IPR of Verinata’s patents related to noninvasive prenatal
testing. 36 The PTAB instituted IPR but, in the final written decision,
concluded that Ariosa failed to meet its burden of showing the challenged
claims were obvious. The PTAB’s analysis included a statement assigning
no weight to an exhibit originally attached to one of Ariosa’s declarations
accompanying its petitions, which Ariosa attempted “through a second
declaration” to “bolster the reliance placed in the Petitions” on that reference.

at Harbor–UCLA Med. Ctr. v. Eli Lilly & Co., 849 F.3d 1049 (Fed. Cir. 2017); Microsoft Corp. v. Parallel
Networks Licensing, LLC, 715 Fed. Appx. 1013 (Fed. Cir. 2017) (unpublished); Rovalma, S.A. v.
Bohler-Edelstahl GmbH & Co., 856 F.3d 1019 (Fed. Cir. 2017); Pers. Web Techs., LLC. v. Apple Inc.,
848 F.3d 987 (Fed. Cir. 2017); Securus Techs., Inc. v. Global Tel*Link Corp., 685 Fed. Appx. 979 (Fed.
Cir. 2017) (unpublished); In re Nuvasive, Inc., 842 F.3d 1376 (Fed. Cir. 2016); Ariosa Diagnostics v.
Verinata Health, Inc., 805 F.3d 1359 (Fed. Cir. 2015).
31. In re Van Os, 844 F.3d 1359, 1360 (Fed. Cir. 2017).
32. Id. at 1361.
33. Id. at 1362 (citing In re Lee, 277 F.3d 1338, 1346 (Fed. Cir. 2002)).
34 Id.
35. Id. at 1363 (Newman, P., concurring in part and dissenting in part).
36. Ariosa Diagnostics v. Verinata Health, Inc., 805 F.3d 1359, 1360 (Fed. Cir. 2015).
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On appeal, Ariosa challenged the PTAB’s treatment of the exhibit,
arguing that the PTAB erred in refusing to consider what background
knowledge a skilled artisan would have possessed about DNA indexing at
the time of the challenged invention.37 The Federal Circuit agreed, reasoning
that it was improper to discount the exhibit because art “can legitimately
serve to document the knowledge that skilled artisans would bring to bear in
reading the prior art identified as producing obviousness.”38 The problem,
however, was that the Federal Circuit could not discern the basis on which
the PTAB discounted the exhibit:
That the language of the Board regarding [the challenged exhibit] is
readily susceptible of being read to rest on an incorrect legal proposition,
by itself, does not require setting aside the Board’s decisions. We may
affirm an agency ruling if we may reasonably discern that it followed a
proper path, even if that path is less than perfectly clear. We also may
affirm if an erroneous portion of an agency’s ruling is ultimately nonprejudicial, i.e., not material to the bottom-line result given other portions
of the agency’s ruling. But we must not ourselves make factual and
discretionary determinations that are for the agency to make. 39

Because the Federal Circuit could not discern the basis on which the
PTAB discounted the exhibit, the Federal Circuit remanded the case. In
remanding on the issue, the Federal Circuit recognized that the Board has
control of its proceedings, and accordingly did not order further briefing or
taking of evidence. 40 Instead, the Federal Circuit left it to the PTAB to
determine the best procedure for ensuring that its next written opinion would
be fully reasoned and APA-compliant.
During remand, the PTAB provided the parties guidance in addressing
the issues the Federal Circuit outlined in the initial ruling.41 Procedurally, the
PTAB held a conference call to discuss the post-remand procedure and
authorized a 15-page brief, 15-page response, and 5-page reply to address
the challenged exhibit. 42 The PTAB would not entertain argument or
evidence not before the Federal Circuit on appeal.43
37. Id. at 1365.
38. Id.
39. Id. at 1365 (citations omitted).
40. Id. at 1367 (leaving to the PTAB the “determination of what remand proceedings are appropriate
given the governing policies.”).
41. Ariosa Diagnostics v. Verinata Health, Inc., No. IPR2013-00276 & IPR2013-00277, 2016 WL
8944596 (P.T.A.B. Aug. 15, 2016).
42. Id. at *2.
43. Id.
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After the submissions, the PTAB concluded, again, that the Petitioner
had not met its burden to determine that the challenged claims were obvious.
The PTAB recognized that the challenged exhibit “may be evidence of the
level of skill in the art.”44 The issue for the PTAB, however, was that the
Petitioner had not explained how the exhibit remedied the deficiencies in the
prior art’s demonstration that the challenged claims were not obvious. 45
Thus, the PTAB concluded, when the prior art was considered in view of the
state of the art as described in the challenged exhibit, there was no “rational
underpinning as to why the ordinary artisan would have combined the cited
teaching to arrive at” the claim limitations.46 In light of Ariosa, practitioners
should carefully tie the evidence to their arguments, lest the PTAB cannot
make out a fully reasoned case.
In another example illustrating the PTAB’s substantive APA
violations, in Rovalma, S.A. v. Bohler-Edelstahl GmbH & Co. KG, the
Federal Circuit remanded the PTAB’s final written decision finding that the
challenged claims relating to hot-work steel with high thermal conductivity
were obvious.47 The Federal Circuit found that the PTAB’s decision was
deficient, on evidentiary and procedural grounds, under the APA. Regarding
evidentiary insufficiency, the Federal Circuit emphasized the importance of
a clear explanation to support an obviousness determination, explaining:
The Supreme Court has recognized the importance of clarity with respect
to obviousness determinations. . . .We have repeatedly insisted on such
explanations in reviewing the adequacy of the Board’s analysis—both as
a matter of obviousness law and as a matter of administrative law. We
have noted that the amount of explanation needed varies from case to case,
depending on the complexity of the matter and the issues raised in the
record.48

The Federal Circuit found that the PTAB failed to meet that standard
because it did not “sufficiently lay out the basis for its implicit findings” on
the question of obviousness.49 The Federal Circuit took issue with the PTAB
finding that a person of ordinary skill in the art would have “inherently”
completed certain of the claimed method steps, when the PTAB had “not
44.
45.
46.
47.
48.
49.

Id. at *9.
Id.
Id. at *10.
856 F.3d 1019, 1021 (Fed. Cir. 2017).
Id. at 1025 (internal citations omitted).
Id.
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explain[ed] the evidentiary basis for those determinations, and [Petitioner]
did not provide any explanation regarding these process claim elements that
the Board could adopt as its own.” 50 Accordingly, the Federal Circuit
remanded the decision to the PTAB for further proceedings to more fully
develop its reasoning so that the Federal Circuit could fully consider
appellee’s substantial-evidence challenge.51
On remand, as in Ariosa, the PTAB first held a teleconference to discuss
post-remand procedures and authorized briefing pertinent to evidence the
PTAB relied on to support its implicit factual findings, how the PTAB
interpreted that evidence, and what inferences the PTAB drew from it.52
In its analysis on remand, the PTAB came to a different conclusion on
the obviousness of the challenged claims by now upholding patentability.
While originally it determined that a person of ordinary skill in the art would
have been motivated to increase the thermal conductivity of prior art steel,
the PTAB recognized that the Federal Circuit disagreed with that
conclusion.53 The Federal Circuit found, instead, that teachings related to
high thermal conductivity did not support a finding of motivation to increase
thermal conductivity. 54 After reviewing the arguments that the Petitioner
reiterated in post-remand briefing related to the prior art, the PTAB
concluded that “the record as a whole does not support a finding that a person
of ordinary skill in the art would have been motivated to increase the thermal
conductivities of hot-work steels as set forth in the challenged claims.” 55
Thus, the PTAB demonstrated that on remand from a Federal Circuit
determination that it has not adequately explained its reasoning, a different
outcome is possible.
IV. PRACTICE TIPS FOR RAISING OR DEFENDING APA CHALLENGES
In short, the Federal Circuit seems sensitive to the PTAB’s thorough
review of the record, and petitioners and patent owners can assist the PTAB
with this analysis. Petitioners and patent owners should start considering
APA issues at the early stages of the case. For petitioners, given tight page
limits and discovery related to the proceedings, focusing in on fewer, more
thoroughly argued positions may be a winning strategy by avoiding
50. Id.
51. Id. at 1026.
52. Bohler-Edelstahl GmbH & Co. KG v. Rovalma, No. IPR2015-00150, Paper 46 at 1 (P.T.A.B.
Dec. 6, 2017).
53. Id. at 4.
54. Id. at 5.
55. Id.
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successful appeals on APA grounds. In particular, petitioners can help ensure
the Final Written Decision is well reasoned by providing ample citations to
record evidence and make explicit the connection from the evidence to the
argued point. Again, because of the limited amount of space, discovery, and
tight timeframe for APJs to arrive at a Final Written Decision, the more
factual support that can shepherd evidence to a legal argument will assist
petitioners’ efforts.
For a party dissatisfied with a Final Written Decision, consider making
an APA-related challenge on appeal. By showing that a Final Written
Decision is not sufficiently reasoned, either because there was an insufficient
explanation of which evidence was relied on or how it was relied on, parties
may be able to secure a remand. And on remand, the key for petitioners is to
link evidence and legal conclusion explicit, and patent owners should explain
how no such link is possible or supported.

